1. Home
  2. EXLS vs RVMD Comparison

EXLS vs RVMD Comparison

Compare EXLS & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXLS
  • RVMD
  • Stock Information
  • Founded
  • EXLS 1999
  • RVMD 2014
  • Country
  • EXLS United States
  • RVMD United States
  • Employees
  • EXLS N/A
  • RVMD N/A
  • Industry
  • EXLS Business Services
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EXLS Consumer Discretionary
  • RVMD Health Care
  • Exchange
  • EXLS Nasdaq
  • RVMD Nasdaq
  • Market Cap
  • EXLS 7.1B
  • RVMD 7.5B
  • IPO Year
  • EXLS 2006
  • RVMD 2020
  • Fundamental
  • Price
  • EXLS $45.22
  • RVMD $38.58
  • Analyst Decision
  • EXLS Strong Buy
  • RVMD Strong Buy
  • Analyst Count
  • EXLS 7
  • RVMD 12
  • Target Price
  • EXLS $49.57
  • RVMD $68.67
  • AVG Volume (30 Days)
  • EXLS 3.3M
  • RVMD 3.1M
  • Earning Date
  • EXLS 07-31-2025
  • RVMD 08-06-2025
  • Dividend Yield
  • EXLS N/A
  • RVMD N/A
  • EPS Growth
  • EXLS 21.21
  • RVMD N/A
  • EPS
  • EXLS 1.32
  • RVMD N/A
  • Revenue
  • EXLS $1,902,884,000.00
  • RVMD N/A
  • Revenue This Year
  • EXLS $14.18
  • RVMD N/A
  • Revenue Next Year
  • EXLS $11.53
  • RVMD $241.39
  • P/E Ratio
  • EXLS $34.16
  • RVMD N/A
  • Revenue Growth
  • EXLS 14.18
  • RVMD N/A
  • 52 Week Low
  • EXLS $31.02
  • RVMD $29.17
  • 52 Week High
  • EXLS $52.43
  • RVMD $62.40
  • Technical
  • Relative Strength Index (RSI)
  • EXLS 48.14
  • RVMD 42.66
  • Support Level
  • EXLS $43.73
  • RVMD $36.37
  • Resistance Level
  • EXLS $45.91
  • RVMD $38.03
  • Average True Range (ATR)
  • EXLS 1.24
  • RVMD 1.47
  • MACD
  • EXLS 0.06
  • RVMD -0.23
  • Stochastic Oscillator
  • EXLS 42.04
  • RVMD 18.71

About EXLS ExlService Holdings Inc.

ExlService Holdings Inc. is a business process management company that provides digital operations and analytical services to clients driving enterprise-scale business transformation initiatives that leverage the company's deep expertise in analytics, AI, ML, and cloud. The company offers business process outsourcing and automation services, and data-driven insights to customers across multiple industries. The company operates through four segments based on the products and services offered and markets served: Insurance, Healthcare, Emerging Business, and Analytics . The vast majority of the company's revenue is earned in the United States, and more than half of its revenue comes from Analytics segment.

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: